SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Stock analysts at Desjardins raised their Q2 2025 earnings estimates for shares of SNC-Lavalin Group in a report issued on Tuesday, July 15th. Desjardins analyst B. Poirier now anticipates that the company will post earnings of $0.69 per share for the quarter, up from their previous forecast of $0.63. Desjardins also issued estimates for SNC-Lavalin Group’s Q3 2025 earnings at $0.89 EPS, Q4 2025 earnings at $1.14 EPS, FY2025 earnings at $3.33 EPS, FY2026 earnings at $4.68 EPS and FY2027 earnings at $5.65 EPS.
Separately, National Bank Financial lowered shares of SNC-Lavalin Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th.
SNC-Lavalin Group Price Performance
About SNC-Lavalin Group
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Articles
- Five stocks we like better than SNC-Lavalin Group
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Stocks to Cushion Your Portfolio This Earnings Season
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- This Fund Manager Says You Should Get Out of Tesla and Apple—Now
- What Are Growth Stocks and Investing in Them
- JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
